Evidence map›Paper›PMID 34480777›Full record

ArticleJournal of clinical pharmacy and therapeutics2021

Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan.

Masami Tsuchiya, Hideyuki Terazono, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical pharmacy and therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Masami TsuchiyaDepartment of Pharmacy, Miyagi Cancer Center, Natori, Japan.ORCID https://orcid.org/0000-0003-3846-0435
Hideyuki TerazonoEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0002-2657-4454
Yosuke MakiEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0002-2534-2782
Naoki YoshikawaEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0002-4928-0395
Yosuke KawaharaEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0002-0720-6904
Keiko NishimuraEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.
Keisuke ShinoharaEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.
Daisuke OgawaEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0003-2263-6352
Riho MoriEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.
Yoshihiro IwamotoEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.
Fumio ItagakiEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0002-2816-6542
Hiroyuki MasukoEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.
Masahito YonemuraEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0003-3143-1826
Mayako UchidaEducation and Training Committee, Japanese Society of Pharmaceutical Oncology (JASPO), Chuo-ku, Japan.ORCID https://orcid.org/0000-0003-0507-7309
Japanese Society of Medical Oncology · JPKagoshima University Hospital · JPKurashiki Central Hospital · JPMiyagi Prefectural Hospital Organization · JPNagasaki Medical Center · JPNational Hospital Organization Hokkaido Medical Center · JPSaku Central Hospital · JPUniversity of Miyazaki Hospital · JP

Funding

Japanese Society of Pharmaceutical Oncology
6 · The paper itself

Abstract

WHAT IS KNOWN AND

objectiveContinuing education is essential for pharmacists to acquire and maintain the knowledge, skills, and ethical attitudes necessary for clinical practice. However, with the emergence of COVID-19, the social circumstances and face-to-face learning environments have changed. The objectives of this study were to determine Japanese pharmacists' perception of a web-based educational programme in oncology, and assess changes in their understanding of pharmaceutical care in oncology before and after their participation in the webinar.

methodsQuestionnaire-based surveys were conducted for the participants of the web-based educational programme to determine their perspectives on the webinar, and their degree of comprehension of the five cancer types covered before and after watching the webinar. RESULTS AND DISCUSSION: Of the 1936 pharmacists taking the programme, all participated in the pre-webinar survey, and 1861 (96.1%) in the post-webinar survey. Compared with previous seminars that were held in the offline mode before the COVID-19 pandemic, 76.8% of respondents were significantly satisfied with the web-based educational programme. The median post-webinar comprehension scores in all modules were significantly higher than the median pre-webinar scores (p < 0.0001). A majority of the participants agreed that a web-based educational programme was satisfactory in acquiring knowledge. WHAT IS NEW AND

conclusionThis web-based educational programme was effective for Japanese pharmacists for postgraduate education in pharmaceutical care in oncology. To the best of our knowledge, our study is the first to report the effectiveness of a web-based educational programme for oncology pharmacists using a large population.

Indexed as

InternetAdultCOVID-19Education, ContinuingEducation, DistanceEducation, PharmacyFemaleHealth Care SurveysHumansJapanMaleMiddle AgedPandemicsPharmacistsProfessional RoleProgram Evaluationclinical pharmacyeducationoncology

Identifiers

PMID34480777
PMCPMC8657323
OpenAlexW3198549950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.